Effectiveness of an intervention to improve the vaccination coverage against Streptococcus pneumoniae in patients with chronic kidney disease

Hum Vaccin Immunother. 2021 Jan 2;17(1):170-172. doi: 10.1080/21645515.2020.1759975. Epub 2020 May 19.

Abstract

Pneumococcal vaccination is recommended for chronic kidney disease (CKD) patients. We evaluated the impact of implementing a hospital vaccine consultation on their vaccination coverages. A sample was drawn from consecutive cases referred to our clinic between November 2014 and June 2018. 101 patients were analyzed: 4 had received the pneumococcal conjugated vaccine 13-valent at the time of the first appointment, whereas 93 had received it after being seen (RR (95%-CI) = 23.3 (8.88-60.85)). Moreover, 5 had received the pneumococcal polysaccharide vaccine 23-valent at the time of the first appointment, whereas 90 had received it after being seen (RR (95%-CI) = 18.0 (7.64-42.42)). Implementing a hospital-based vaccine consultation represents an effective intervention to improve pneumococcal vaccination coverage in these patients.

Keywords: Vaccination Coverage; chronic; pneumococcal Vaccines; referral and Consultation; renal Insufficiency.

Publication types

  • Letter

MeSH terms

  • Humans
  • Pneumococcal Infections* / prevention & control
  • Pneumococcal Vaccines
  • Renal Insufficiency, Chronic* / complications
  • Streptococcus pneumoniae
  • Vaccination
  • Vaccination Coverage
  • Vaccines, Conjugate

Substances

  • Pneumococcal Vaccines
  • Vaccines, Conjugate

Grants and funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.